Květná 15, 603 00 Brno, epodatelna
szpi.gov.cz
Data box ID: avraiqg
IČO: 75014149, DIČ: CZ75014149
Privacy Policy
Czech Agriculture and Food Inspection Authority (CAFIA) ordered to immediately withdraw the VASOGEN preparation with date of usable life of 15.11.2005 from circulation. This freely available preparation provably contains „sildenafil“, which is pharmacologically effective substance and must not be used without medical prescription. Sildenafil, that can be, under certain circumstances, a threat to consumer´s health, is not declared in VASOGEN, even though, according to the State Institute for Drug Control, this substance has a lot of contraindications, for example cardiovascular disorders, heart attack, strokes or serious liver disorders, etc. Therefore the preparation cannot be used with any medical exam. In addition to this, CAFIA have found out further differences in labelling of this product.
VASOGEN produced by American company Ultra Health Products Inc., is imported to the Czech Republic by P.A.A. Agency s.r.o. and is put into circulation as a food additive for support of sexual functions.
According to the current findings of CAFIA, there are only two batches of VASOGEN in circulation, of which that one, labelled with the date of usable life of 15.11.2005, provably contains sildenafil.
CAFIA then ordered to the importer to withdraw it immediately from circulation and to publish information about undesirable impacts of VASOGEN on its own web sites and also wherever this preparation has been sold. Concerning the second batch, the importer is obliged to provide information about ingredients to CAFIA. The importer is also obliged to inform quickly about every further delivery of this product. CAFIA has also given a report to Rapid Alert Systém for Food and Feed (RASFF) about this finding, who warns control organizations of all EU countries.
On the basis of information from the American Food and Drug Administration /FDA/, this undeclared „sildenafil“ has been also found out in a food additive named VINAROL , sold in USA. It was produced by the Ultra Health Products Inc., as well. But after inspection of FDA they have willingly withdrawn it from circulation.
CAFIA warn consumers of possible health hazard and recommend consultations with doctors.
Photo: View of product (front, back and site) and fly sheets.